Cargando…

Era of COVID-19 in Multiple Sclerosis Care

The unprecedented scope of the coronavirus disease 2019 (COVID-19) pandemic resulted in numerous disruptions to daily life, including for people with multiple sclerosis (PwMS). In this article, we review how disruptions in MS care prompted innovations in delivery of care (e.g., via telemedicine) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krett, Jonathan D., Salter, Amber, Newsome, Scott D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288315/ https://www.ncbi.nlm.nih.gov/pubmed/37980121 http://dx.doi.org/10.1016/j.ncl.2023.06.006

Ejemplares similares

Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
por: Coyle, Patricia K., et al.
Publicado: (2021)

Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
por: Coyle, Patricia K., et al.
Publicado: (2021)

Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration
por: Racke, Michael K., et al.
Publicado: (2020)

The pressing questions in multiple sclerosis Care in the era of COVID-19
por: Abboud, Hesham, et al.
Publicado: (2020)

Clinical trials in multiple sclerosis: milestones
por: Zhang, Yinan, et al.
Publicado: (2018)

Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
por: Monschein, Tobias, et al.
Publicado: (2021)

Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era
por: Nicholas, Jacqueline A., et al.
Publicado: (2021)

Early Aggressive Treatment Approaches for Multiple Sclerosis
por: Simpson, Alexandra, et al.
Publicado: (2021)

Evolution of clinical trials in multiple sclerosis
por: Zhang, Yinan, et al.
Publicado: (2019)

Providing Person-Centered Care via Telemedicine in the Era of COVID-19 in Multiple Sclerosis
por: Abbatemarco, Justin R, et al.
Publicado: (2021)

Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis
por: Salter, Amber, et al.
Publicado: (2021)

Impact of COVID-19 on prescribing patterns and treatment selection of disease modifying therapies in multiple sclerosis
por: Zaheer, Reemal, et al.
Publicado: (2023)

Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
por: Porwal, Mokshal H., et al.
Publicado: (2022)

Telemedicine and Multiple Sclerosis Management in the Era of COVID-19, Al-Azhar Experience
por: Essmat, Ahmed
Publicado: (2022)

Uptake and Attitudes About Immunizations in People With Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis
por: Chiaravalloti, Nancy D., et al.
Publicado: (2020)

Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate
por: Ma, Brandy B., et al.
Publicado: (2016)

Attitudes of people with multiple sclerosis toward brain donation
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Health Literacy Association With Health Behaviors and Health Care Utilization in Multiple Sclerosis: A Cross-Sectional Study
por: Marrie, Ruth Ann, et al.
Publicado: (2014)

Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice
por: Longbrake, Erin E, et al.
Publicado: (2016)

Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach
por: Immovilli, Paolo, et al.
Publicado: (2022)

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID-19 era
por: Toscano, Simona, et al.
Publicado: (2022)

A survey of risk tolerance to multiple sclerosis therapies
por: Fox, Robert J., et al.
Publicado: (2019)

COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes()
por: Salter, Amber, et al.
Publicado: (2022)

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Retrograde trans-synaptic visual pathway degeneration in multiple sclerosis: A case series
por: Al-Louzi, Omar, et al.
Publicado: (2017)

Disease-modifying therapy prescription patterns in people with multiple sclerosis by age
por: Zhang, Yinan, et al.
Publicado: (2021)

Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era
por: Kasarello, Kaja, et al.
Publicado: (2021)

Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis
por: Scott, Thomas F, et al.
Publicado: (2016)

Correction to: Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID‑19 era
por: Toscano, Simona, et al.
Publicado: (2022)

COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry
por: Newsome, Scott D., et al.
Publicado: (2021)

Severity and worsening of fatigue among individuals with multiple sclerosis
por: Salter, Amber, et al.
Publicado: (2023)

Preferred Sources of Health Information in Persons With Multiple Sclerosis: Degree of Trust and Information Sought
por: Marrie, Ruth Ann, et al.
Publicado: (2013)

Vaccination of multiple sclerosis patients during the COVID-19 era: Novel insights into vaccine safety and immunogenicity
por: Kim, Enoch, et al.
Publicado: (2022)

A narrative review of neuro-ophthalmologic disease in African Americans and Hispanics with multiple sclerosis
por: Tardo, Lauren, et al.
Publicado: (2023)

Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey
por: Rinker, John R, et al.
Publicado: (2015)

Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bt5q01vt7qfl0n11n0j73b522l